On Friday, Paychex, Inc. (NASDAQ:PAYX)’s shares declined -3.40% to $45.69.
For the second straight month, the Paychex | IHS Small Business Jobs Index was relatively unchanged, increasing slightly from 100.63 in June to 100.64 in July. The national index has seen little movement in recent months, essentially remaining flat from May to July. Still trailing employment growth seen in 2014, the index was down 0.46 percent from the previous July. The East North Central region continues as the highest-ranked regional index. Washington maintained its lead among states, and for the 10th straight month, Dallas ranked number one among metro areas for employment growth with an index level surpassing 105.
Paychex, Inc. provides payroll, human resource, insurance, and benefits outsourcing solutions for small to medium-sized businesses in the United States and Germany. The company offers payroll processing services that comprise the calculation, preparation, and delivery of employee payroll checks; production of internal accounting records and administration reports; preparation of federal, state, and local payroll tax returns; and collection and remittance of clients payroll obligations.
Mobil’nye Telesystemy PAO (ADR) (NYSE:MBT)’s shares dropped -7.11% to $7.06.
Mobile TeleSystems PJSC (MBT), the leading telecommunications provider in Russia and the CIS, recently declares its unaudited IFRS financial results for the three months ended June 30, 2015.
Key Financial Highlights of Q2 2015
- Merged group revenue raised 3.9% y-o-y to RUB 102.7 bln
- Total revenue in Russia rose 4.4% y-o-y to RUB 94.3 bln
- Mobile service revenue in Russia improved 2.8% y-o-y to RUB 72.7 bln
- Data traffic revenue in Russia grew 23.4% y-o-y to RUB 18.9 bln
- Handset sales raised 26.7% y-o-y to RUB 7.6 bln
- Group OIBDA down 2.1% to RUB 42.7 bln
- OIBDA in Russia rose 2.2% y-o-y to RUB 41.2 bln
- MTS reaffirms its Group guidance:
- Group revenue growth of more than 2%.
- Revenue growth in MTS Russia more than 3%.
Mobile TeleSystems Public Joint Stock Company provides telecommunication services in Russia and the Commonwealth of Independent States. It offers a range of mobile and fixed line voice and data telecommunications services, counting data transfer, broadband, pay-TV, and various value-added services, in addition to sells equipment and accessories. The company also provides voice and SMS-based value-added services; and Internet access.
At the end of Friday’s trade, Esperion Therapeutics Inc (NASDAQ:ESPR)‘s shares surged 2.85% to $54.47.
Esperion Therapeutics, Inc. (ESPR), an emerging pharmaceutical company focused on developing and commercializing first-in-class, oral, low-density lipoprotein cholesterol (LDL-cholesterol) lowering therapies for the treatment of patients with hypercholesterolemia and other cardiometabolic risk markers, recently offered ETC-1002 (bempedoic acid) development program updates and financial results for the second quarter ended June 30, 2015.
Development Program and Company Highlights
- June 15, 2015: Dr. Mary McGowan designated Chief Medical Officer, and Dr. Scott Braunstein elected to the board of directors.
- July 7, 2015: Removal of the 240 mg partial clinical hold by the FDA, allowing ETC-1002 to be used at doses above 240 mg in clinical studies.
- July 28, 2015: Positive top-line Phase 2 results declared for ETC-1002-014 in patients with both hypercholesterolemia and hypertension.
- July 30, 2015: Second annual analyst and investor day.
Esperion Therapeutics, Inc., a biopharmaceutical company, focuses on the research, development, and commercialization of oral and low-density lipoprotein cholesterol lowering therapies for the treatment of patients with hypercholesterolemia and other cardiometabolic risk markers. Its products comprise ETC-1002, an oral molecule therapy that is in Phase 2b clinical trials to treat patients with hypercholesterolemia, in addition to to lower levels of LDL-cholesterol, and avoid various side effects associated with LDL-cholesterol lowering therapies.
Mentor Graphics Corp(NASDAQ:MENT), ended its Friday’s trading session with -0.12% loss, and closed at $25.05.
Mentor Graphics Corporation ( MENT ) declared financial results for the companys fiscal second quarter ended July 31, 2015. The company stated revenues of $281.1 million, non-GAAP earnings per share of $0.36, and GAAP earnings per share of $0.26.
Revenue was an all-time second quarter record and Mentor exceeded non-GAAP earnings per share guidance for the 26th successive quarter, said Walden C. Rhines, chairman and CEO. Customer need for raised amounts of software drove early renewal activity and the upside in the quarter. Demand was strongest in both Design to Silicon and Scalable Verification. During the quarter we added five new emulation customers, counting both a Top Ten chip company and a start-up.
Mentor Graphics Corporation provides electronic design automation software and hardware solutions to automate the design, analysis, and testing of electro-mechanical systems, electronic hardware, and embedded systems software. The company offers Mentor Graphics Scalable Verification tools; Questa platform to verify systems and integrated circuits (ICs); analog/mixed signal simulation tools, counting Eldo, ADVance MS, and ADiT; and Veloce, a hardware emulation system.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.
